The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Continued cetuximab in second-line treatment for patients with unresectable metastatic wild-type KRAS, NRAS, and BRAF colorectal cancer after disease progression during first-line cetuximab-based therapy.
 
Ying Liu
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Ning Ma
No Relationships to Disclose
 
Shuning Xu
No Relationships to Disclose
 
Lei Qiao
No Relationships to Disclose
 
Ke Li
No Relationships to Disclose
 
Gaizhen Kuang
No Relationships to Disclose
 
Danyang Li
No Relationships to Disclose
 
Yangyang Liu
No Relationships to Disclose
 
Yanyan Xiong
No Relationships to Disclose
 
Mingming Sun
No Relationships to Disclose